Ozalin (Midazolam)

Midazolam, the active ingredient in Ozalin, is a benzodiazepine presented as a 5 mg/ml injection for intravenous use. It is employed for sedation, anxiolysis, and seizure control in hospital settings. GNH USA supplies Ozalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ozalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Midazolam is a short‑acting benzodiazepine that acts on the central nervous system to produce sedation and seizure control.

- Pre‑operative sedation: Provides rapid onset sedation before surgical procedures. - Status epilepticus: Controls acute seizure activity when rapid control is needed. - Procedural sedation: Enables safe sedation for diagnostic or therapeutic procedures. - Intensive care unit ICU ICU ICU ... ... ... ... ...  ...  ...  ...

Midazolam  … … … ... ... … … ... ... ... ...